The diverse expression of the WT1 gene in patients with acquired bone marrow failure syndromes

References

• Ge M, Shi J, Li X, et al. Clinical features and prognostic factors of Asian patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China. Acta Haematol. 2015;134:1–6.
   PubMed Web of Science ®Google Scholar
• Young NS, Meyers G, Schrezenmeier H, et al. The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients. Semin Hematol. 2009;46:S1–S16.
   PubMed Web of Science ®Google Scholar
• Ueda Y, Mizutani C, Nannya Y, et al. Clinical evaluation of WT1 mRNA expression level in peripheral blood and bone marrow in patients with myelodysplastic syndromes. Leuk Lymphoma. 2013;54:1450–1458.
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Ge M, et al. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience. Ann Hematol. 2011;90:529–537.
   PubMed Web of Science ®Google Scholar
• Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361:1872–1885.
   PubMed Web of Science ®Google Scholar
• Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699–3709.
   PubMed Web of Science ®Google Scholar
• Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172:187–207.
   PubMed Web of Science ®Google Scholar
• Nakao S. Diagnostic problems in acquired bone marrow failure syndromes. Int J Hematol. 2016;104:151–152.
   PubMed Web of Science ®Google Scholar
• Nakao S, Gale RP. Are mild/moderate acquired idiopathic aplastic anaemia and low-risk myelodysplastic syndrome one or two diseases or both and how should it/they be treated? Blood. 2016;30:2127–2130.
   Google Scholar
• Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell. 1990;60:509–520.
   PubMed Web of Science ®Google Scholar
• Guglielmelli P, Zini R, Bogani C, et al. Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). Stem Cells. 2007;25:165–173.
   PubMed Web of Science ®Google Scholar
• Gallo D, Nicoli P, Calabrese C, et al. The Wilms’ tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy. Cancer Med. 2016;5:1650–1653.
   PubMed Web of Science ®Google Scholar
• Szántó A, Pap Z, Dénes L, et al. Real-time quantitative PCR detection of WT1 and M-BCR-ABL expressions in chronic myeloid leukemia. Rom J Morphol Embryol. 2015;56:703–707.
   PubMed Web of Science ®Google Scholar
• Hu SY, Gu WY, Chen ZX, et al. The significance of detecting WT1 expression in childhood acute leukemias. Pediatr Hematol Oncol. 2010;27:581–591.
   PubMed Web of Science ®Google Scholar
• Olszewski M, Huang W, Chou PM, et al. Wilms’ tumor 1 (WT1) gene in hematopoiesis: a surrogate marker of cell proliferation as a possible mechanism of action? Cytotherapy. 2005;7:57–61.
   PubMed Web of Science ®Google Scholar
• Shichishima T, Okamoto M, Ikeda K, et al. HLA class II haplotype and quantitation of WT1 RNA in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood. 2002;100:22–28.
   PubMed Web of Science ®Google Scholar
• Armstrong JF, Pritchard-Jones K, Bickmore WA, et al. The expression of the Wilms’ tumor gene, WT1, in the developing mammalian embryo. Mech Dev. 1993;40:85–97.
   PubMed Web of Science ®Google Scholar
• Menssen HD, Renkl H-J, Entezami M, et al. Wilms’ tumor gene expression in human CD34+ hematopoietic progenitors during fetal development and early clonogenic growth. Blood. 1997;89:3486–3487.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Matsuda Y, Takai M, et al. Wilms’ tumor-1 transcript in peripheral blood helps diagnose acute myeloid leukemia and myelodysplastic syndrome in patients with pancytopenia. Anticancer Res. 2012;32:4479–4483.
   PubMed Web of Science ®Google Scholar
• Baba M, Hata T, Tsushima H, et al. The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasons. Intern Med. 2015;54:445–451.
   PubMed Web of Science ®Google Scholar
• Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976;48:63–70.
   PubMed Web of Science ®Google Scholar
• Li X, Shi J, Ge M, et al. Outcomes of optimized over standard protocol of rabbit antithymocyte globulin for severe aplastic anemia: a single-center experience. PLoS One. 2013;8:e56648.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–2405.
   PubMed Web of Science ®Google Scholar
• Nand S, Godwin JE. Hypoplastic myelodysplastic syndrome. Cancer. 1988;62:958–964.
   PubMed Web of Science ®Google Scholar
• Maschek H, Kaloutsi V, Rodriguez-Kaiser M, et al. Hypoplastic myelodysplastic syndrome: incidence, morphology, cytogenetics, and prognosis. Ann Hematol. 1993;66:117–122.
   PubMed Web of Science ®Google Scholar
• Beillard E, Pallisgaard N, van der Velden, et al. Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program. Leukemia. 2003;17:2474–2486.
   PubMed Web of Science ®Google Scholar
• Kreuzer KA, Saborowski A, Lupberger J, et al. Fluorescent 50-exonuclease assay for the absolute quantification of Wilms’ tumour gene (WT1) mRNA: implications for monitoring human leukaemias. Br J Haematol. 2001;114:313–318.
   PubMed Web of Science ®Google Scholar
• Cilloni D, Gottardi E, Messa F, et al. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. JCO. 2003;21:1988–1995.
   PubMed Web of Science ®Google Scholar
• Qin YZ, Liu YR, Zhu HH, et al. Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response. Int J Lab Hematol. 2008;30:317–323.
   PubMed Web of Science ®Google Scholar
• Qin Y, Zhu H, Jiang B, et al. Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease. Leuk Res. 2009;33:384–390.
   PubMed Web of Science ®Google Scholar
• Baird PN, Simmons PJ. Expression of the Wilms’ tumor gene (WT1) in normal hemopoiesis. Exp Hematol. 1997;25:312–320.
   PubMed Web of Science ®Google Scholar
• Maurer U, Brieger J, Weidmann E, et al. The Wilms tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. Exp Hematol. 1997;25:945–950.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Jones RJ. Aplastic anemia. Lancet. 2005;365:1647–1656.
   PubMed Web of Science ®Google Scholar
• Scopes J, Bagnara M, Gordon-Smith EC, et al. Haemopoietic progenitor cells are reduced in aplastic anaemia. Br J Haematol. 1994;86:427–430.
   PubMed Web of Science ®Google Scholar
• Inoue K, Tamaki H, Ogawa H, et al. Wilms’ tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood. 1998;91:2969–2976.
   PubMed Web of Science ®Google Scholar
• Tsuboi A, Oka Y, Ogawa H, et al. Constitutive expression of the Wilms’ tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Leuk Res. 1999;23:499–505.
   PubMed Web of Science ®Google Scholar
• Gurbuxani S. WT1 expression in myelodysplastic syndrome. Leuk Lymphoma. 2007;48:456–457.
   PubMed Web of Science ®Google Scholar
• Li X, Wu L, Ying S, et al. Wilms’ tumor gene (WT1) is predominantly expressed in clonal hematopoietic cells in myelodysplastic syndromes. Leuk Lymphoma. 2007;48:601–604.
   PubMed Web of Science ®Google Scholar